µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
Ç×¾ÏÁ¦ (Oncology)
 
Ç¥ÀûÄ¡·á Ç×¾ÏÁ¦(Targeted cancer therapy)

´ÜÀÏÁ¦ ÃÑ 43°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
bortezomib 3.5mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
gemtuzumab ozogamicin 5mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
alemtuzumab 30mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
ibritumomab tiuxetan 1.6mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
temsirolimus 30mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Olaparib 50mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
bortezomib trimer 2.4mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Blinatumomab 38.5§¶ÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
olaratumab 500mgÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
vismodegib 150mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
niraparib tosylate monohydrate 100mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
ixazomib citrate 3.29mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
ixazomib citrate 4.3mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
ixazomib citrate 5.7mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
venetoclax 10mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
venetoclax 50mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
venetoclax 100mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Olaparib 150mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Olaparib 100mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
talazoparib tosylate 1.453mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
[1]
º¹ÇÕÁ¦ ÃÑ4°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
Trastuzumab 0.6g ¿Ü 1°³ÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Trastuzumab 0.6g ¿Ü 1°³ÁÖ»çÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
niraparib tosylate monohydrate 159.4mg ¿Ü 1°³Á¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
niraparib tosylate monohydrate 79.7mg ¿Ü 1°³Á¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
[1]
 
ºñÆ®µå·¯±×ÀÎÆ÷